StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Clene Inc.
NasdaqCM:CLNN
Sector
Location
Market Cap
USD 32.88 M
Share Price
USD 3.66
Avg Daily Volume
92,468
Change (1 day)
-2.14%
Change (1 year)
-19.20%
Change (YTD)
-31.07%
Clene Inc. EBT Margin for the Trailing 12 Months (TTM) ending March 31, 2025: -8,306.00%
Clene Inc. EBT Margin is -8,306.00% for the Trailing 12 Months (TTM) ending March 31, 2025. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.
-
Clene Inc. EBT Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -5,151.64%, a -270.60% change year over year.
-
Clene Inc. EBT Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 3,019.63%, a -119.25% change year over year.
-
Clene Inc. EBT Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was -15,689.97%, a -33.08% change year over year.
Competitors
Chugai Pharmaceutical Co., Ltd.
USD 49.80
4519.T
+0.60
1.22%
MERCK Kommanditgesellschaft auf Aktien
USD 133.12
MRK.DE
+0.98
0.74%
Agilent Technologies, Inc.
USD 120.35
A
+0.88
0.74%
Qiagen N.V.
USD 51.23
QGEN
+0.83
1.65%
Aurobindo Pharma Limited
USD 12.94
AUROPHARMA.NS
+0.05
0.41%
Yuhan Corporation
USD 89.51
000100.KS
-0.12
-0.13%
Pharmaron Beijing Co., Ltd.
USD 2.87
3759.HK
+0.23
8.72%
Repligen Corporation
USD 121.87
RGEN
+4.74
4.05%
Bruker Corporation
USD 40.45
BRKR
+0.54
1.35%
Bachem Holding AG
USD 94.22
BANB.SW
+22.18
30.80%
Siegfried Holding AG
USD 119.47
SFZN.SW
+5.12
4.48%
Gan & Lee Pharmaceuticals.
USD 8.33
603087.SS
+0.11
1.30%
Cohance Lifesciences Limited
USD 11.90
COHANCE.NS
-0.08
-0.66%
Metsera, Inc.
USD 39.66
MTSR
-0.34
-0.84%
Bloomage BioTechnology Corporation Limited
USD 7.65
688363.SS
+0.42
5.73%
Syngene International Limited
USD 7.89
SYNGENE.NS
+0.14
1.86%
Jafron Biomedical Co.,Ltd.
USD 3.22
300529.SZ
+0.07
2.21%
Beijing Hotgen Biotech Co., Ltd.
USD 26.48
688068.SS
+0.77
3.00%
Anhui Anke Biotechnology (Group) Co., Ltd.
USD 1.34
300009.SZ
+0.03
2.43%
Changzhou Qianhong Biopharma CO.,LTD
USD 1.57
002550.SZ
-0.02
-1.33%
Key Data
| Date | EBT Margin | Operating Income Margin | Gross Profit Margin | EBIT Margin |
|---|
Competitors
Chugai Pharmaceutical Co., Ltd.
USD 49.80
4519.T
+0.60
1.22%
MERCK Kommanditgesellschaft auf Aktien
USD 133.12
MRK.DE
+0.98
0.74%
Agilent Technologies, Inc.
USD 120.35
A
+0.88
0.74%
Qiagen N.V.
USD 51.23
QGEN
+0.83
1.65%
Aurobindo Pharma Limited
USD 12.94
AUROPHARMA.NS
+0.05
0.41%
Yuhan Corporation
USD 89.51
000100.KS
-0.12
-0.13%
Pharmaron Beijing Co., Ltd.
USD 2.87
3759.HK
+0.23
8.72%
Repligen Corporation
USD 121.87
RGEN
+4.74
4.05%
Bruker Corporation
USD 40.45
BRKR
+0.54
1.35%
Bachem Holding AG
USD 94.22
BANB.SW
+22.18
30.80%
Siegfried Holding AG
USD 119.47
SFZN.SW
+5.12
4.48%
Gan & Lee Pharmaceuticals.
USD 8.33
603087.SS
+0.11
1.30%
Cohance Lifesciences Limited
USD 11.90
COHANCE.NS
-0.08
-0.66%
Metsera, Inc.
USD 39.66
MTSR
-0.34
-0.84%
Bloomage BioTechnology Corporation Limited
USD 7.65
688363.SS
+0.42
5.73%
Syngene International Limited
USD 7.89
SYNGENE.NS
+0.14
1.86%
Jafron Biomedical Co.,Ltd.
USD 3.22
300529.SZ
+0.07
2.21%
Beijing Hotgen Biotech Co., Ltd.
USD 26.48
688068.SS
+0.77
3.00%
Anhui Anke Biotechnology (Group) Co., Ltd.
USD 1.34
300009.SZ
+0.03
2.43%
Changzhou Qianhong Biopharma CO.,LTD
USD 1.57
002550.SZ
-0.02
-1.33%